Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases consisting of syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

Trinity Biotech plc

Trinity Biotech ( ($TRIB) ) has issued an announcement. On March 11, 2026, Trinity Biotech said senior executives would attend the ATTD 2026 diabet...

Current Yield	N/A	Payout Ratio	N/A
Annual DPS	$0.00	Growth Streak	5 years
Ex-Dividend	Invalid Date	Pay Date	7/1/2015
Record Date	6/9/2015	Declaration	Invalid Date
Frequency	NA	Quarterly Est	$0.00

Date	Jun 2015	Stock Price	$448.25	TTM Div	$0.22	Yield	0.05%
Date	Jun 2014	Stock Price	$594.25	TTM Div	$0.22	Yield	0.04%
Date	Jun 2013	Stock Price	$432.00	TTM Div	$0.20	Yield	0.05%
Date	Jun 2012	Stock Price	$283.75	TTM Div	$0.15	Yield	0.05%
Date	Jun 2011	Stock Price	$248.00	TTM Div	$0.10	Yield	0.04%

Ex-Date	Amount	Declared	Record	Pay Date	Type	Freq
6/5/2015	$0.2200	Invalid Date	-	-	2015-07-01	2015-06-09
6/6/2014	$0.2200	Invalid Date	-	-	2014-07-01	2014-06-10
6/6/2013	$0.2000	Invalid Date	-	-	2013-07-01	2013-06-10
6/6/2012	$0.1500	Invalid Date	-	-	2012-06-22	2012-06-08
6/7/2011	$0.1000	Invalid Date	-	-	2011-06-23	2011-06-09

	A	B	C	D
1	Symbol	Price	Change	Volume
2	TRIB	$0.70	0.00%	365.96K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	TRIB	$0.70	0%	365.96K
3
4
5
6

TRIB

TRIB

Dividend Overview

Dividend Yield History

Stock Price

TTM Dividend Payout

TTM Dividend Yield

Historical Yield Data

Recent Dividend History

Get Trinity Biotech plc Data in Excel

Get Trinity Biotech plc Data in Excel